Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Circulation

• Publication date

  1988-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.77.2.361PMID 2962786
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Platelet accumulation in experimental angioplasty: time course and relation to vascular injury.

  1987cited by this paper
• Recurrence after coronary angioplasty.

  1987cited by this paper
• Is vasospasm related to platelet deposition? Relationship in a porcine preparation of arterial injury in vivo.

  1987cited by this paper
• Recurrence after coronary angioplasty.

  1987cited by this paper
• Quantitative Coronary and Left Ventricular Cineangiography: Methodology and Clinical Applications

  1986cited by this paper
• Changes in cross-sectional area of the coronary lumen in the six months after angioplasty: a quantitative analysis of the variable response to percutaneous transluminal angioplasty.

  1986cited by this paper
• Quantitative Coronary and Left Ventricular Cineangiography

  1986cited by this paper
• A second look at quantitative coronary angiography: some unexpected problems

  1986cited by this paper
• Morphology of the coronary arteries after combined thrombolysis and percutaneous transluminal coronary angioplasty for acute myocardial infarction.

  1986cited by this paper
• Restenosis after successful coronary angioplasty in patients with single-vessel disease.

  1986cited by this paper
• Approaches towards standardization in acquisition and quantitation of arterial dimensions from cineangiograms

  1986cited by this paper
• Coronary angioplasty: clinical and angiographic follow-up.

  1985cited by this paper
• Percutaneous transluminal coronary angioplasty: role in the treatment of coronary artery disease.

  1985cited by this paper
• Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms.

  1985cited by this paper
• Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model.

  1985cited by this paper
• Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty.

  1985cited by this paper
• Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty.

  1985cited by this paper
• Atrial fibrillation in patients with Wolff-Parkinson-White syndrome: incidence after surgical ablation of the accessory pathway.

  1985cited by this paper
• Intimal hyperplasia as a cause of restenosis after percutaneous transluminal coronary angioplasty.

  1985cited by this paper
• Recurrence rate after successful coronary angioplasty.

  1985cited by this paper
• Early detection of restenosis after successful percutaneous transluminal coronary angioplasty by exercise-redistribution thallium scintigraphy.

  1985cited by this paper
• Estimation of the effects of angioplasty on coronary stenosis using quantitative video angiography.

  1985cited by this paper
• Emergency coronary angioplasty in refractory unstable angina.

  1985cited by this paper
• Surgery, Angioplasty or Drugs?

  1985cited by this paper
• DIGITAL RADIOGRAPHIC CORONARY ARTERY QUANTIFICATION.

  1985cited by this paper
• Assessment of percutaneous transluminal coronary angioplasty by quantitative coronary angiography: diameter versus densitometric area measurements.

  1984cited by this paper
• Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study.

  1984cited by this paper
• Detection and quantitation of coronary artery stenoses from digital subtraction angiograms compared with 35-millimeter film cineangiograms.

  1984cited by this paper
• Repeat coronary angioplasty.

  1984cited by this paper
• Restenosis after transluminal coronary angioplasty detected with exercise-gated radionuclide ventriculography.

  1984cited by this paper
• Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute.

  1984cited by this paper
• Pathological findings after percutaneous transluminal coronary angioplasty.

  1984cited by this paper
• Transluminal coronary angioplasty and early restenosis. Fibrocellular occlusion after wall laceration.

  1983cited by this paper
• Status of the major epicardial coronary arteries 80 to 150 days after percutaneous transluminal coronary angioplasty. Analysis of 3 necropsy patients.

  1983cited by this paper
• Computerized image analysis for quantitative measurement of vessel diameter from cineangiograms.

  1983cited by this paper
• Percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris: analysis of early and late results.

  1983cited by this paper
• AUTOMATED EVALUATION OF VESSEL DIAMETER FROM ARTERIOGRAMS.

  1983cited by this paper
• Percutaneous transluminal coronary angioplasty. The first five years and the future.

  1983cited by this paper
• Assessment of stenoses in coronary angioplasty. Inter- and intraobserver variability.

  1983cited by this paper
• The unpredictable progression of symptomatic coronary artery disease: a serial clinical-angiographic analysis.

  1981cited by this paper
• The mechanism of balloon angioplasty.

  1980cited by this paper
• Cine-densitometric measurement of coronary arterial stenoses.

  1979cited by this paper
• Variability in the Analysis of Coronary Arteriograms

  1977cited by this paper
• Quantitative Coronary Arteriography: Estimation of Dimensions, Hemodynamic Resistance, and Atheroma Mass of Coronary Artery Lesions Using the Arteriogram and Digital Computation

  1977cited by this paper
• Interobserver Variability in Coronary Angiography

  1976cited by this paper
• Platelet factors stimulate fibroblasts and smooth muscle cells quiescent in plasma serum to proliferate

  1976cited by this paper
• A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association.

  1975cited by this paper
• Observer Agreement in Evaluating Coronary Angiograms

  1975cited by this paper
• Electrocardiographic classification for population comparisons. The Minnesota code.

  1969cited by this paper

• Drug-Eluting Resorbable Scaffolds

  2026cites this paper
• PAPP-A Protein Diagnostic and Prognostic Significance in Acute Coronary Syndromes Without Persistent ST-T-Segment Elevation.

  2026cites this paper
• Innovations in Vascular Repair from Mechanical Intervention to Regenerative Therapies

  2025cites this paper
• Indications for Use of Drug-Coated Balloons in Coronary Intervention: Academic Research Consortium Position Statement.

  2025cites this paper
• Evolution of Coronary Stents: From Birth to Future Trends

  2025cites this paper
• Coronary Angioplasty with Drug-Coated Balloons: Pharmacological Foundations, Clinical Efficacy, and Future Directions

  2025cites this paper
• Coronary angiography: a review of the state of the art and the evolution of angiography in cardio therapeutics

  2024cites this paper
• Editorial: Is the axiom of balloon angioplasty, "the more you gain the more you lose", still true in the era of DCB with paclitaxel?

  2024cites this paper
• Modification of 316L Stainless Steel, Nickel Titanium, and Cobalt Chromium Surfaces by Irreversible Immobilization of Fibronectin: Towards Improving the Coronary Stent Biocompatibility

  2024cites this paper
• Enhancing Flexibility of Smart Bioresorbable Vascular Scaffolds through 3D Printing using Polycaprolactone and Polylactic Acid

  2024cites this paper
• Phellinus merrillii extracts induce apoptosis of vascular smooth muscle cells via intrinsic and extrinsic pathways

  2023cites this paper
• A Prospective Randomized Trial Comparing Sirolimus-Coated Balloon With Paclitaxel-Coated Balloon in De Novo Small Vessels.

  2023cites this paper
• Migration of endothelial cells on the surface of anodized Ni-Ti stent strut

  2023cites this paper
• A Synopsis of Stent Graft Technology Development

  2023cites this paper
• Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench-to-bedside.

  2022cites this paper
• Curcumin’s Antioxidant Properties in Stable Coronary Artery Disease Patients Undergoing Percutaneous Coronary Intervention: A Randomized Controlled Trial

  2022cites this paper
• Stent visualization methods to guide percutaneous coronary interventions and assess long-term patency

  2021cites this paper
• Periodontitis Is Associated With Risk of Conventional Stent Restenosis: Pilot Case-Control Study

  2021cites this paper
• Curcumin's Effect on Inflammatory Response following Percutaneous Coronary Intervention in Adult Patients with Stable Coronary Heart Disease

  2021cites this paper
• First-in-Man trial of a drug-free bioresorbable stent designed to minimize the duration of coronary artery scaffolding

  2021cites this paper
• The use of poly(styrene-block-isobutylene-block-styrene) and analogs for long-term implant applications

  2021cites this paper
• Emerging therapies in coronary balloon angioplasty, stenting, and bioabsorbable scaffolds

  2020cites this paper
• Prozedurale Komplikationen

  2020cites this paper
• Sustained safety and efficacy of the magnesium scaffold: does the Magmaris scaffold call for the return of BRS research… and randomised controlled trials?

  2020cites this paper
• Impact of Dissection after Drug-Coated Balloon Treatment of De Novo Coronary Lesions: Angiographic and Clinical Outcomes

  2020cites this paper
• From Stenosis to Restenosis - The New Coronary Artery Disease Continuum in the PCI Era

  2020cites this paper
• Twelve-month clinical and imaging outcomes of the uncaging DynamX Bioadaptor System.

  2020cites this paper
• The 2010s in clinical drug-eluting stent and bioresorbable scaffold research: a Dutch perspective

  2020cites this paper
• Biodegradable Metal Coronary Stents: Material Options From Perspective of Biodegradability and Biocompatibility

  2020cites this paper
• Identification of atherosclerotic plaques in intravascular optical coherence tomography images based on textures and artificial neural network

  2020cites this paper
• Two-year longitudinal evaluation of a second-generation thin-strut sirolimus-eluting bioresorbable coronary scaffold with hybrid cell design in porcine coronary arteries.

  2020cites this paper
• Influence of the Adopted Balloon Modeling Strategies in the Stent Deployment Procedure: An In-Silico Analysis

  2020cites this paper
• Influence of the Adopted Balloon Modeling Strategies in the Stent Deployment Procedure: An In-Silico Analysis

  2020cites this paper
• Ultrasound monitoring of magnet-guided delivery of mesenchymal stem cells labeled with magnetic lipid-polymer hybrid nanobubbles.

  2020cites this paper
• Transmembrane protein 66 attenuates neointimal hyperplasia after carotid artery injury by SOCE inactivation.

  2019cites this paper
• OCT for Bioabsorbable Vascular Scaffold

  2019cites this paper
• Migration versus proliferation as contributor to in vitro wound healing of vascular endothelial and smooth muscle cells

  2019cites this paper
• Predictors of In-Stent Restenosis after Coronary Angioplasty

  2019cites this paper
• A numerical corrosion-fatigue model for biodegradable Mg alloy stents.

  2019cites this paper
• Serial Optical Coherence Tomography at Baseline, 7 Days, and 1, 3, 6 and 12 Months After Bioresorbable Scaffold Implantation in a Growing Porcine Model.

  2019cites this paper
• Tuning structural relaxations, mechanical properties, and degradation timescale of PLLA during hydrolytic degradation by blending with PLCL-PEG

  2019cites this paper
• LIM-only protein FHL2 attenuates inflammation in vascular smooth muscle cells through inhibition of the NFκB pathway.

  2019cites this paper
• Recent Advances in Managing Atherosclerosis via Nanomedicine.

  2018cites this paper
• A one-step hydrothermal process to fabricate superhydrophobic hydroxyapatite coatings and determination of their properties

  2018cites this paper
• Fate of post-procedural malapposition of everolimus-eluting polymeric bioresorbable scaffold and everolimus-eluting cobalt chromium metallic stent in human coronary arteries: sequential assessment with optical coherence tomography in ABSORB Japan trial

  2018cites this paper
• Photodynamic therapy of balloon-injured rat carotid arteries using indocyanine green

  2018cites this paper
• The evolution of coronary stents

  2018cites this paper
• Multicentre, randomised, blinded, control trial of drug-eluting balloon vs Sham in recurrent native dialysis fistula stenoses

  2018cites this paper
• Layered double hydroxide/poly-dopamine composite coating with surface heparinization on Mg alloys: improved anticorrosion, endothelialization and hemocompatibility.

  2018cites this paper
• Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy.

  2018cites this paper
• The Role of Exercise Test After Percutaneous Coronary Intervention

  2018cites this paper
• An overview of pleiotropic effect of statins in cardiovascular disease

  2018cites this paper
• The development of bioresorbable composite polymeric implants with high mechanical strength.

  2018cites this paper
• An overview of patented technology for fully‐degradable polylactic acid stents

  2018cites this paper
• Mussel-inspired elastic interpenetrated network hydrogel as an alternative for anti-thrombotic stent coating membrane

  2018cites this paper
• Bio-resorbable polymer stents: a review of material progress and prospects

  2018cites this paper
• Acute and Chronic Vascular Effects of Percutaneous Coronary Interventions

  2017cites this paper
• An in vivo pilot study of a microporous thin film nitinol-covered stent to assess the effect of porosity and pore geometry on device interaction with the vessel wall

  2017cites this paper
• Nanoengineered Stent Surface to Reduce In-Stent Restenosis in Vivo.

  2017cites this paper
• Bioabsorbable Scaffolds: Can the Problems of Dissolution Be Overcome?

  2017cites this paper
• An assessment of the use of the ABSORB bioresorbable vascular scaffold in the treatment of 'false' coronary bifurcations

  2017cites this paper
• Evaluation of bioresorbable polymers as potential stent material- In vivo degradation behavior and histocompatibility

  2017cites this paper
• Bioresorbable Polymers and Stent Devices

  2017cites this paper
• Differences in Vascular Response between Balloon Overstretch and Stent Overexpansion in Nonatherosclerotic Porcine Coronary Arteries.

  2017cites this paper
• Scaffold bioriassorbibile: l’esperienza clinica della Regione Emilia-Romagna

  2017cites this paper
• État des lieux des pratiques de pose d'endoprothèses coronaires et impact sur les complications au Centre Hospitalier d'Ajaccio

  2017cites this paper
• Coronary balloon angioplasty, stents, and scaffolds.

  2017cites this paper
• State of the art: coronary angiography.

  2017cites this paper
• A Four-Year Follow-Up Randomized Comparison of Coronary Stent Implantation and Balloon Angioplasty in the Treatment of De Novo Coronary Artery Lesions ( START ) A Four-Year Follow-up

  2016cites this paper
• Bioresorbable scaffold - A magic bullet for the treatment of coronary artery disease?

  2016cites this paper
• Suivi longitudinal des endoprothèses coronaires par analyse de séquences d'images de tomographie par cohérence optique.

  2016cites this paper
• Przewrót w leczeniu choroby niedokrwiennej serca – rola kardiologii interwencyjnej = The revolution in the treatment of ischaemic heart disease – the role of interventional cardiology

  2016cites this paper
• Comparative Characterization of Biomechanical Behavior and Healing Profile of a Novel Ultra-High-Molecular-Weight Amorphous Poly-L-Lactic Acid Sirolimus-Eluting Bioresorbable Coronary Scaffold

  2016cites this paper
• Recombinant Human Elastase Alters the Compliance of Atherosclerotic Tibial Arteries After Ex Vivo Angioplasty

  2016cites this paper
• Bioresorbable coronary scaffolds should disappear faster.

  2016cites this paper
• Polo-Like Kinase 1 and Smooth Muscle Cells in Coronary Artery Bypass Conduits and Coronary Arteries Following Angioplasty

  2016cites this paper
• 3 Testa et al BVS Technology to Treat CAD Bioresorbable Vascular Scaffold Use in the Clinical Arena : Evidence From the Absorb Trials and Registries Absorb Trials

  2016cites this paper
• Optimization of structural and mechanical properties of electro-spun biodegradable scaffolds for vascular tissue regeneration

  2016cites this paper
• Coronary Bioresorbable Vascular Scaffold Use in the Treatment of Coronary Artery Disease

  2016cites this paper
• Vascular Stem/Progenitor Cell Migration Induced by Smooth Muscle Cell‐Derived Chemokine (C‐C Motif) Ligand 2 and Chemokine (C‐X‐C motif) Ligand 1 Contributes to Neointima Formation

  2016cites this paper
• Paving the way to a bioresorbable technology: Development of the absorb BRS program

  2016cites this paper
• Percutaneous coronary interventions of bifurcation lesions

  2016cites this paper
• Bioresorbable Scaffolds: The Revolution in Coronary Stenting?

  2016cites this paper
• Four-year polymer biocompatibility and vascular healing profile of a novel ultrahigh molecular weight amorphous PLLA bioresorbable vascular scaffold: an OCT study in healthy porcine coronary arteries.

  2016cites this paper
• [SICI-GISE Position paper: Use of Absorb BVS in clinical practice].

  2016cites this paper
• Modeling biodegradable stents and their effect on the arterial wall

  2016cites this paper
• Biomechanical Challenges to Polymeric Biodegradable Stents

  2016cites this paper
• CLINICAL Benefit of Coronary Stenting Versus Balloon Angioplasty: One-Year Cliqieal Foll~w4Jp of Benestent Trial

  2016cites this paper
• Design Principles of Bioresorbable Polymeric Scaffolds.

  2016cites this paper
• EXPERIMENTAL STUDIES Local Delivery of Biodegradable Microparticles or a Colchicine Analogue: Effects on Restenosis

  2016cites this paper
• Advanced Stents for Cardiovascular Applications

  2016cites this paper
• A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis: 5-Year Follow-Up.

  2016cites this paper
• Delayed progressive bilateral supraclinoid internal carotid artery stenosis in a patient with a ruptured basilar artery aneurysm.

  2015cites this paper
• Absorb bioresorbable vascular scaffold: What have we learned after 5 years of clinical experience?

  2015cites this paper
• Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty

  2015cites this paper
• The effects of Educative Supportive Nursing Program on Dietary Behavior Among Patients After Percutaneous Transluminal Coronary Intervention

  2015cites this paper
• Vascular Proteomics Reveal Novel Proteins Involved in SMC Phenotypic Change: OLR1 as a SMC Receptor Regulating Proliferation and Inflammatory Response

  2015cites this paper
• Bioresorbable scaffolds: focus on vascular response and long-term safety.

  2015cites this paper
• Coronary Artery Bypass Surgery and Percutaneous Coronary Revascularization: Impact on Morbidity and Mortality in Patients with Coronary Artery Disease

  2015cites this paper
• Predictors and impact of target vessel revascularization after stent implantation for acute ST-segment elevation myocardial infarction: lessons from HORIZONS-AMI.

  2015cites this paper